Structural vulnerabilities and PrEP awareness among Boston heterosexuals and people who inject drugs at risk for HIV: findings from 2018 to 2019 cycles from the Boston, MA site of the NHBS

References

• Algarin, A. B., Ibañez, G. E., Forrest, D. W., Faraldo, M., Spencer, E. C., & Maddox, L. (2022). Examining the psychometrics of the National HIV Behavioral Surveillance measure for community HIV-related stigma. AIDS and Behavior, 26(1), 252–260. https://doi.org/10.1007/s10461-021-03378-7
   PubMed Web of Science ®Google Scholar
• Assoumou, S. A., Paniagua, S. M., Gonzalez, P., Wang, J., Beckwith, C. G., White, L. F., Taylor, J. L., Coogan, K., Samet, J. H., & Linas, B. P. (2021). HIV pre-exposure prophylaxis and buprenorphine at a drug detoxification center during the opioid epidemic: Opportunities and challenges. AIDS and Behavior, 25(8), 2591–2598. https://doi.org/10.1007/s10461-021-03220-0
   PubMed Web of Science ®Google Scholar
• Calabrese, S. K. (2020). Understanding, contextualizing, and addressing PrEP stigma to enhance PrEP implementation. Current HIV/AIDS Reports, 17(6), 579–588. https://doi.org/10.1007/s11904-020-00533-y
   PubMed Web of Science ®Google Scholar
• CDC. (2018, December 11). National HIV behavioral surveillance system round 5: Model surveillance protocol. www.cdc.gov/hiv/statistics/systems/nhbs/operations.html
   Google Scholar
• CDC. (2021, November 23). PrEP for HIV prevention in the U.S. https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/PrEP-for-hiv-prevention-in-the-US-factsheet.html
   Google Scholar
• CDC. (2022, May 24). HIV surveillance report, 2020; vol. 33. https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-33/index.html
   Google Scholar
• Chudasama, Y. V., Gillies, C. L., Zaccardi, F., Coles, B., Davies, M. J., Seidu, S., & Khunti, K. (2020). Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 965–967. https://doi.org/10.1016/j.dsx.2020.06.042
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., Feelemyer, J., McKnight, C., Barnes, D. M., Perlman, D. C., Uuskula, A., Cooper, H. L. F., & Tross, S. (2018). Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000–2017: Protective effects of non-injecting drug use. Drug and Alcohol Dependence, 192, 74–79. https://doi.org/10.1016/j.drugalcdep.2018.07.034
   PubMed Web of Science ®Google Scholar
• Earlywine, J. J., Bazzi, A. R., Biello, K. B., & Klevens, R. M. (2021). High prevalence of indications for pre-exposure prophylaxis among people who inject drugs in Boston, Massachusetts. American Journal of Preventive Medicine, 60(3), 369–378. https://doi.org/10.1016/j.amepre.2020.09.011
   PubMed Web of Science ®Google Scholar
• Fauci, A. S., Redfield, R. R., Sigounas, G., Weahkee, M. D., & Giroir, B. P. (2019). Ending the HIV epidemic: A plan for the United States. JAMA, 321(9), 844–845. https://doi.org/10.1001/jama.2019.1343
   PubMed Web of Science ®Google Scholar
• FDA. (2012). Truvada for PrEP fact sheet: Ensuring safe and proper use. https://www.fda.gov/media/83586/download
   Google Scholar
• Grov, C., Westmoreland, D. A., D’Angelo, A. B., & Pantalone, D. W. (2021). How has HIV pre-exposure prophylaxis (PrEP) changed sex? A review of research in a new era of bio-behavioral HIV prevention. The Journal of Sex Research, 58(7), 891–913. https://doi.org/10.1080/00224499.2021.1936440
   PubMed Web of Science ®Google Scholar
• Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations*. Social Problems, 44(2), 174–199. https://doi.org/10.2307/3096941
   Web of Science ®Google Scholar
• Hedrick, A. M., & Carpentier, F. R. D. (2021). How current and potential pre-exposure prophylaxis (PrEP) users experience, negotiate and manage stigma: Disclosures and backstage processes in online discourse. Culture, Health & Sexuality, 23(8), 1079–1093. https://doi.org/10.1080/13691058.2020.1752398
   PubMed Web of Science ®Google Scholar
• Hillis, A., Germain, J., Hope, V., McVeigh, J., & Van Hout, M. C. (2020). Pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM): A scoping review on PrEP service delivery and programming. AIDS and Behavior, 24(11), 3056–3070. https://doi.org/10.1007/s10461-020-02855-9
   PubMed Web of Science ®Google Scholar
• Jones, J. T., Smith, D. K., Wiener, J., August, E. M., Finlayson, T., Wejnert, C., & for the National HIV Behavioral Surveillance Study Group. (2021). Assessment of PrEP awareness, PrEP discussion with a provider, and PrEP use by transmission risk group with an emphasis on the Southern United States. AIDS and Behavior, 25(9), 2985–2991. https://doi.org/10.1007/s10461-021-03164-5
   PubMed Web of Science ®Google Scholar
• Kim, E. J., Marrast, L., & Conigliaro, J. (2020). COVID-19: Magnifying the effect of health disparities. Journal of General Internal Medicine, 35(8), 2441–2442. https://doi.org/10.1007/s11606-020-05881-4
   PubMed Web of Science ®Google Scholar
• Kudrati, S. Z., Hayashi, K., & Taggart, T. (2021). Social media & PrEP: A systematic review of social media campaigns to increase PrEP awareness & uptake among young Black and Latinx MSM and women. AIDS and Behavior, 25(12), 4225–4234. https://doi.org/10.1007/s10461-021-03287-9
   PubMed Web of Science ®Google Scholar
• McFarland, W., Lin, J., Santos, G.-M., Arayasirikul, S., Raymond, H. F., & Wilson, E. (2020). Low PrEP awareness and use among people who inject drugs, San Francisco, 2018. AIDS and Behavior, 24(5), 1290–1293. https://doi.org/10.1007/s10461-019-02682-7
   PubMed Web of Science ®Google Scholar
• Mistler, C. B., Copenhaver, M. M., & Shrestha, R. (2021). The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: A systematic review. AIDS & Behavior, 25(5), 1490–1506. https://doi.org/10.1007/s10461-020-02988-x
   PubMed Web of Science ®Google Scholar
• Pampati, S., Emrick, K., Siegler, A. J., & Jones, J. (2021). Changes in sexual behavior, PrEP adherence, and access to sexual health services because of the COVID-19 pandemic among a cohort of PrEP-using MSM in the South. Journal of Acquired Immune Deficiency Syndromes (1999), 87(1), 639–643. https://doi.org/10.1097/QAI.0000000000002640
   PubMed Web of Science ®Google Scholar
• Pinto, R. M., Berringer, K. R., Melendez, R., & Mmeje, O. (2018). Improving PrEP implementation through multilevel interventions: A synthesis of the literature. AIDS and Behavior, 22(11), 3681–3691. https://doi.org/10.1007/s10461-018-2184-4
   PubMed Web of Science ®Google Scholar
• Pinto, R. M., Lacombe-Duncan, A., Kay, E. S., & Berringer, K. R. (2019). Expanding knowledge about implementation of pre-exposure prophylaxis (PrEP): A methodological review. AIDS and Behavior, 23(10), 2761–2778. https://doi.org/10.1007/s10461-019-02577-7
   PubMed Web of Science ®Google Scholar
• R Development Core Team. (2016). R: A language and environment for statistical computing (3.3.2) [Windows]. R Foundation for Statistical Computing. http://www.R-project.org
   Google Scholar
• Sherman, S. G., Schneider, K. E., Park, J. N., Allen, S. T., Hunt, D., Chaulk, C. P., & Weir, B. W. (2019). PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug and Alcohol Dependence, 195, 148–155. https://doi.org/10.1016/j.drugalcdep.2018.08.014
   PubMed Web of Science ®Google Scholar
• Silapaswan, A., Krakower, D., & Mayer, K. H. (2017). Pre-exposure prophylaxis: A narrative review of provider behavior and interventions to increase PrEP implementation in primary care. Journal of General Internal Medicine, 32(2), 192–198. https://doi.org/10.1007/s11606-016-3899-4
   PubMed Web of Science ®Google Scholar
• Sophus, A. I., & Mitchell, J. W. (2019). A review of approaches used to increase awareness of Pre-exposure prophylaxis (PrEP) in the United States. AIDS and Behavior, 23(7), 1749–1770. https://doi.org/10.1007/s10461-018-2305-0
   PubMed Web of Science ®Google Scholar
• Sullivan, P. S., & Siegler, A. J. (2018). Getting pre-exposure prophylaxis (PrEP) to the people: Opportunities, challenges and emerging models of PrEP implementation. Sexual Health, 15(6), 522. https://doi.org/10.1071/SH18103
   PubMed Web of Science ®Google Scholar
• Walters, S. M., Kral, A. H., Simpson, K. A., Wenger, L., & Bluthenthal, R. N. (2020). HIV pre-exposure prophylaxis prevention awareness, willingness, and perceived barriers among people who inject drugs in Los Angeles and San Francisco, CA, 2016–2018. Substance Use & Misuse, 55(14), 2409–2419. https://doi.org/10.1080/10826084.2020.1823419
   PubMed Web of Science ®Google Scholar